![]() Faculty Information |
|
Article types | Original article |
Language | English |
Refereed paper | Refereed |
Title | Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child-Pugh class A or B liver function in real-world clinical practice |
Journal | Formal name:Hepatology Research ISSN code:13866346 |
Domestic / Foregin | Foregin |
Volume, Number, Page | 52(9),pp.773-783 |
Papers・Author | Tanaka Takaaki, Hiraoka Atsushi, Tada Toshifumi, Hirooka Masashi, Kariyama Kazuya, Tani Joji, Atsukawa Masanori, Takaguchi Koichi, Itobayashi Ei, Fukunishi Shinya, Tsuji Knihiro, Ishikawa Toru, Tajiri Kazuto, Ochi Hironori, Yasuda Satoshi, Toyoda Hidenori, Ogawa Chikara, Nishimura Takashi, Hatanaka Takeshi, Kakizaki Satoru, Shimada Noritomo, Kawata Kazuhiro, Naganuma Atsushi, Kosaka Hisashi, Ohama Hideko, Nouso Kazuhiro, Morishita Asahiro, Tsutsui Akemi, Nagano Takua, Itokawa Norio, Okubo Tomomi, Arai Taeang, Imai Michitaka, Koizumi Yohei, Nakamura Shinichiro, Joko Kouji, Iijima Hiroko, Kaibori Masaki, Hiasa Yoichi, Kudo Masatoshi, Kumada Takashi; Real-life Practice Experts for HCC (RELPEC) Study Group; HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). |
Publication date | 2022/05 |